AAAAAA

   
Results: 1-10 |
Results: 10
Management of von Willebrand disease: a survey on current clinical practice from the haemophilia centres of North America
Authors: Cohen, AJ Kessler, CM Ewenstein, BM
Citation: Aj. Cohen et al., Management of von Willebrand disease: a survey on current clinical practice from the haemophilia centres of North America, HAEMOPHILIA, 7(3), 2001, pp. 235-241
Use of ristocetin cofactor activity in the management of von Willebrand disease
Authors: Ewenstein, BM
Citation: Bm. Ewenstein, Use of ristocetin cofactor activity in the management of von Willebrand disease, HAEMOPHILIA, 7, 2001, pp. 10-15
Regulated secretion in endothelial cells: Biology and clinical implications
Authors: Datta, YH Ewenstein, BM
Citation: Yh. Datta et Bm. Ewenstein, Regulated secretion in endothelial cells: Biology and clinical implications, THROMB HAEM, 86(5), 2001, pp. 1148-1155
Continuous infusion of recombinant factor VIIa: Continue or not?
Authors: Ewenstein, BM
Citation: Bm. Ewenstein, Continuous infusion of recombinant factor VIIa: Continue or not?, THROMB HAEM, 86(4), 2001, pp. 942-944
Risk factors for infection with HBV and HCV in a large cohort of hemophiliac males
Authors: Soucie, JM Richardson, LC Evatt, BL Linden, JV Ewenstein, BM Stein, SF Leissinger, C Manco-Johnson, M Sexauer, CL
Citation: Jm. Soucie et al., Risk factors for infection with HBV and HCV in a large cohort of hemophiliac males, TRANSFUSION, 41(3), 2001, pp. 338-343
Immune tolerance induction in hemophilia patients with inhibitors: costly can be cheaper
Authors: Colowick, AB Bohn, RL Avorn, J Ewenstein, BM
Citation: Ab. Colowick et al., Immune tolerance induction in hemophilia patients with inhibitors: costly can be cheaper, BLOOD, 96(5), 2000, pp. 1698-1702
Targeting of a heterologous protein to a regulated secretion pathway in cultured endothelial cells
Authors: Datta, YH Youssoufian, H Marks, PW Ewenstein, BM
Citation: Yh. Datta et al., Targeting of a heterologous protein to a regulated secretion pathway in cultured endothelial cells, BLOOD, 94(8), 1999, pp. 2696-2703
Anionic polysaccharides inhibit adhesion of sickle erythrocytes to the vascular endothelium and result in improved hemodynamic behavior
Authors: Barabino, GA Liu, XD Ewenstein, BM Kaul, DK
Citation: Ga. Barabino et al., Anionic polysaccharides inhibit adhesion of sickle erythrocytes to the vascular endothelium and result in improved hemodynamic behavior, BLOOD, 93(4), 1999, pp. 1422-1429
Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors
Authors: Key, NS Aledort, LM Beardsley, D Cooper, HA Davignon, G Ewenstein, BM Gilchrist, GS Gill, JC Glader, B Hoots, WK Kisker, CT Lusher, JM Rosenfield, CG Shapiro, AD Smith, H Taft, E
Citation: Ns. Key et al., Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors, THROMB HAEM, 80(6), 1998, pp. 912-918
Variation in incidence of indinavir-associated nephrolithiasis among HIV-positive patients
Authors: Brodie, SB Keller, MJ Ewenstein, BM Sax, PE
Citation: Sb. Brodie et al., Variation in incidence of indinavir-associated nephrolithiasis among HIV-positive patients, AIDS, 12(18), 1998, pp. 2433-2437
Risultati: 1-10 |